Clinical Trial Results

Showing: All studies [change]
Condition: Multiple Sclerosis Location: Kansas 13 trials found
New Search
Filter
Trial Phase
Study Type
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Dry Needling in Multiple Sclerosis
NAINTERVENTIONAL Kansas City, Kansas
RECRUITING
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
PHASE2INTERVENTIONAL Kansas City, Kansas
RECRUITING
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
PHASE1, PHASE2INTERVENTIONAL Kansas City, Kansas +1 more
RECRUITING
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection
PHASE2INTERVENTIONAL Kansas City, Kansas
RECRUITING
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Pheonix, Arizona +4 more
RECRUITING
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type